Press Releases

Press Releases

Biothera Pharmaceuticals, Inc. today announced a collaboration with Merck, known as MSD outside the United States and Canada, to expand the companies’ ongoing clinical program evaluating KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 inhibitor, in combination with Biothera’s Imprime PGG, a Pathogen Associated Molecular Patterning molecule, or PAMP. Imprime PGG acts as an…

Press Releases

SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical development company, announced today that it has been awarded a contract for up to $5.3 million by the Biomedical Advanced Research and Development Authority (BARDA) within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and…

Press Releases

Raptor Pharmaceutical Corp., a biopharmaceutical company developing and commercializing transformative treatments for rare diseases, today announced it will be participating in the European Respiratory Society (ERS) International Congress 2016 and will present data from a systematic literature review and network meta-analysis comparing the efficacy of QUINSAIR™, an inhaled formulation of…

Press Releases

Webinar: Cell Based Assays in Research and Development of New Therapeutic Proteins Monday 3rd October 2016 | 2pm GMT (UK Time) Hosted by Elena Fonfria, Principal Scientist, Ipsen Bioinnovation •    Introduction to cell based assays in research •    Exciting developments of new therapeutic proteins •    Selection of the right cellular…

Press Releases

Pfizer's proposed acquisition of Medivation highlights the trend of large innovative US pharmaceutical firms continuing to pursue targeted acquisitions rather than large transformative ones, according to Fitch Ratings. Consolidation continues as big pharmaceutical firms search for scale and efficiencies. However, as the number of new drugs in the pipeline increases,…

Press Releases

Marken announced today that their Moscow depot was granted a new pharmaceutical license from the Russian Federation. In addition to the storage and transportation of drugs used in clinical trials as a service offered by all of Marken's depots, Marken's newest Moscow Depot will now be legally authorized to perform…

Press Releases

Regeneron Pharmaceuticals, Inc. announced an agreement with the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS) to manufacture and study two antibody therapies for the potential prevention and treatment of Middle East Respiratory Syndrome (MERS). Regeneron has previously published details on…

Press Releases

ImmunoCellular Therapeutics, Ltd. today announced financial results for the second quarter of 2016. Andrew Gengos, ImmunoCellular Chief Executive Officer, commented: "We are pleased with the progress we made in the first half of this year, and believe that 2016 will be a year of accomplishment for our company. The first…

Press Releases

Sophiris Bio Inc., a biopharmaceutical company developing PRX302 (topsalysin) for the treatment of urological diseases, today announced that it intends to offer and sell, subject to market and other conditions, its common shares and warrants to purchase additional common shares in an underwritten public offering. There can be no assurance…

Press Releases

Array BioPharma Inc. today announced that results from a Phase 2 study of ARRY-797 will be presented at the 2016 European Society of Cardiology (ESC) Congress, which will be held August 27 – 31, 2016 in Rome, Italy. POSTER PRESENTATION Title: Phase 2 study of A797, an oral, selective p38…